Advanced Proteome Therapeutics Stock Price on November 7, 2024

APTCF Stock  USD 0.0002  0.00  0.00%   
If you're considering investing in Advanced Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Advanced Proteome stands at 0.0002, as last reported on the 13th of December 2024, with the highest price reaching 0.0002 and the lowest price hitting 0.0002 during the day. We have found three technical indicators for Advanced Proteome Therapeutics, which you can use to evaluate the volatility of the firm.
  
Advanced Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
APTCF
Based on monthly moving average Advanced Proteome is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Advanced Proteome by adding Advanced Proteome to a well-diversified portfolio.

Advanced Proteome Valuation on November 7, 2024

It is possible to determine the worth of Advanced Proteome on a given historical date. On November 7, 2024 Advanced was worth 2.0E-4 at the beginning of the trading date compared to the closed value of 2.0E-4. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Advanced Proteome pink sheet. Still, in general, we apply an absolute valuation method to find Advanced Proteome's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Advanced Proteome where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Advanced Proteome's related companies.
 Open High Low Close Volume
  0.0002    0.0002    0.0002    0.0002    1.00  
11/07/2024
  0.0002    0.0002    0.0002    0.0002    1.00  
  0.0002    0.0002    0.0002    0.0002    1.00  
Backtest Advanced Proteome  |  Advanced Proteome History  |  Advanced Proteome Valuation   PreviousNext  
Open Value
2.0E-4
2.0E-4
Closing Value
0.00
Upside

Advanced Proteome Trading Date Momentum on November 7, 2024

On November 08 2024 Advanced Proteome Therapeutics was traded for  0.0002  at the closing time. The highest daily price throughout the period was 0.0002  and the lowest price was  0.0002 . There was no trading activity during the period 1.0. Lack of trading volume on 11/08/2024 did not affect price variability. The overall trading delta to current closing price is 0.00% .

Advanced Proteome Fundamentals Correlations and Trends

By evaluating Advanced Proteome's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Advanced Proteome's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Advanced financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Advanced Proteome Pink Sheet history

Advanced Proteome investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Advanced is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Advanced Proteome will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Advanced Proteome stock prices may prove useful in developing a viable investing in Advanced Proteome
Advanced Proteome Therapeutics Corporation, through its subsidiary, Advanced Proteome Therapeutics Inc., operates as a biotechnology company in the United States. Its platform is dedicated to applications in the field of antibody drug conjugates, as well as focused on protein conjugates and immunomodulation. Advanced Proteome operates under Biotechnology classification in the United States and is traded on OTC Exchange.

Advanced Proteome Pink Sheet Technical Analysis

Advanced Proteome technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
A focus of Advanced Proteome technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Advanced Proteome trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Advanced Proteome Period Price Range

Low
December 13, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Advanced Proteome Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Advanced Proteome December 13, 2024 Market Strength

Market strength indicators help investors to evaluate how Advanced Proteome pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Advanced Proteome shares will generate the highest return on investment. By undertsting and applying Advanced Proteome pink sheet market strength indicators, traders can identify Advanced Proteome Therapeutics entry and exit signals to maximize returns

Complementary Tools for Advanced Pink Sheet analysis

When running Advanced Proteome's price analysis, check to measure Advanced Proteome's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Advanced Proteome is operating at the current time. Most of Advanced Proteome's value examination focuses on studying past and present price action to predict the probability of Advanced Proteome's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Advanced Proteome's price. Additionally, you may evaluate how the addition of Advanced Proteome to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum